Barbara Weber, M.D.

Barbara Weber, M.D.

Executive ChairmanatTango Therapeutics· In proxies 2022–2025

Pay in FY2025-57% from the year before · Tango Therapeutics stock +186.7% the same year

Barbara Weber, M.D. was paid $2.8M in FY2025 (Dec), down 57%. Tango Therapeutics stock rose 186.7% that year.

Pay$100 in the stock at the end of FY21 → $81
Pay is from the Summary Compensation Table of each Tango Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Tango TherapeuticsPublic company · 4 yr
    • Executive Chairman2022 – Present · 4 yrStock in role +107%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?